Sinovac Biotech Ltd Long-term Investment Intensity
Sinovac Biotech Ltd long-term investment intensity. Sinovac Biotech Ltd (SVA) has a Long-term Investment Intensity of 7.1% as of June 2026. Long-term investments of $576.09 Million represent 7.1% of total assets of $8.14 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Sinovac Biotech Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Sinovac Biotech Ltd (2021–2025)
Long-term investment intensity of Sinovac Biotech Ltd from 2021 to 2025. This chart shows how Sinovac Biotech Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the intensity stands at 7.1%, reflecting long-term investments of $576.09 Million against total assets of $8.14 Billion USD. See defensive interval ratio of Sinovac Biotech Ltd to measure how many days the company can operate on defensive assets alone.
Sinovac Biotech Ltd Long-term Investment Intensity by Year (2021–2025)
Sinovac Biotech Ltd long-term investment intensity by year from 2021 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Sinovac Biotech Ltd from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Sinovac Biotech Ltd.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 5.9% | $512.32 Million | $8.64 Billion | ▲ +2.0 pp |
| 2024 | 4.0% | $491.35 Million | $12.34 Billion | ▼ -1.0 pp |
| 2023 | 5.0% | $684.28 Million | $13.66 Billion | ▲ +0.3 pp |
| 2022 | 4.7% | $661.44 Million | $14.11 Billion | ▲ +0.8 pp |
| 2021 | 3.9% | $655.84 Million | $16.75 Billion | — |